IP-10 is critical for effector T cell trafficking and host survival in Toxoplasma gondii infection

被引:262
作者
Khan, IA
MacLean, JA
Lee, FS
Casciotti, L
DeHaan, E
Schwartzman, JD
Luster, AD [1 ]
机构
[1] Harvard Univ, Massachusetts Gen Hosp, AIDS Res Ctr, Sch Med,Allergy & Immunol Unit,Infect Dis Unit, Boston, MA 02114 USA
[2] Dartmouth Med Ctr, Dept Med, Hanover, NH 03755 USA
[3] Dartmouth Med Ctr, Dept Pathol, Hanover, NH 03755 USA
关键词
D O I
10.1016/S1074-7613(00)80200-9
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The generation of an adaptive immune response against intracellular pathogens requires the recruitment of effector T cells to sites of infection. Here we show that the chemokine IP-10, a specific chemoattractant for activated T cells, controls this process in mice naturally infected with Toxoplasma gondii. Neutralization of IP-10 in infected mice inhibited the massive influx of T cells into tissues and impaired antigen-specific T cell effector functions. This resulted in >1000-fold increase in tissue parasite burden and a marked increase in mortality compared to control antibody-treated mice. These observations suggest that IP-10 may play a broader role in the localization and function of effector T cells at sites of Th1 inflammation.
引用
收藏
页码:483 / 494
页数:12
相关论文
共 48 条
[21]   DETECTION OF A GAMMA-INTERFERON-INDUCED PROTEIN IP-10 IN PSORIATIC PLAQUES [J].
GOTTLIEB, AB ;
LUSTER, AD ;
POSNETT, DN ;
CARTER, DM .
JOURNAL OF EXPERIMENTAL MEDICINE, 1988, 168 (03) :941-948
[22]   Mice lacking expression of secondary lymphoid organ chemokine have defects in lymphocyte homing and dendritic cell localization [J].
Gunn, MD ;
Kyuwa, S ;
Tam, C ;
Kakiuchi, T ;
Matsuzawa, A ;
Williams, LT ;
Nakano, H .
JOURNAL OF EXPERIMENTAL MEDICINE, 1999, 189 (03) :451-460
[23]  
HAKIM FT, 1991, J IMMUNOL, V147, P2310
[24]   INDUCTION OF CD4(+) AND CD8(+) T-CELL RESPONSES IN EFFERENT LYMPH RESPONDING TO TOXOPLASMA-GONDII INFECTION - ANALYSIS OF PHENOTYPE AND FUNCTION [J].
INNES, EA ;
PANTON, WRM ;
SANDERSON, A ;
THOMSON, KM ;
WASTLING, JM ;
MALEY, S ;
BUXTON, D .
PARASITE IMMUNOLOGY, 1995, 17 (03) :151-160
[25]   SCID MOUSE MODELS OF ACUTE AND RELAPSING CHRONIC TOXOPLASMA-GONDII INFECTIONS [J].
JOHNSON, LL .
INFECTION AND IMMUNITY, 1992, 60 (09) :3719-3724
[26]  
KHAN IA, 1991, J IMMUNOL, V147, P3501
[27]  
Khan IA, 1996, J IMMUNOL, V157, P2103
[28]   INDUCTION OF ANTIGEN-SPECIFIC HUMAN CYTOTOXIC T-CELLS BY TOXOPLASMA-GONDII [J].
KHAN, IA ;
SMITH, KA ;
KASPER, LH .
JOURNAL OF CLINICAL INVESTIGATION, 1990, 85 (06) :1879-1886
[29]  
KHAN IA, 1994, J IMMUNOL, V152, P1856
[30]   Measurement of the efficacy of vaccines and antimicrobial therapy against infection with Toxoplasma gondii [J].
Kirisits, MJ ;
Mui, E ;
McLeod, R .
INTERNATIONAL JOURNAL FOR PARASITOLOGY, 2000, 30 (02) :149-155